The Indian Council of Medical Research (ICMR) and Panacea Biotec have announced the initiation of the first-ever Phase 3 clinical trial for a dengue vaccine in India. This landmark trial will evaluate the efficacy of India's indigenous tetravalent dengue vaccine, DengiAll, developed by Panac
New Delhi [India], June 30 (ANI): Orders have been given for the setting up of a lab for genome sequencing at the Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences in Rohtak after the first Delta Plus COVID variant was found in Chandigarh.
Rohtak (Haryana) [India], December 18 (ANI): The condition of Haryana Health Minister Anil Vij, who is undergoing treatment for COVID-19 at the Medanta Hospital in Gurugram, is stable and his vitals parameters are normal, Dr AK Dubey, Medical Superintendent, of the hospital on Thursday.
Rohtak (Haryana) [India], November 19 (ANI): Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak, hopes to get 1,000 healthy volunteers by Thursday for the third-phase trial of Bharat Biotech's COVID-19 vaccine candidate, Covaxin, that will begin from F